home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

Adjuvants Improve The Efficacy Of Vaccines By Switching On Bcl-3 Gene

 
  May, 6 2001 20:51
your information resource in human molecular genetics
 
     
Adjuvants promote cell survival

The ability of individuals to respond to invading pathogens is dependent on immune cells called T lymphocytes. When T cells encounter pathogens they undergo rapid cell division followed by rapid cell death, leaving behind a small pool of "memory" T cells that protect animals from future attack by the same organism. Vaccination relies on developing a substantial pool of memory cells and that is why adjuvants, which can increase T cell survival, are so important. In the May issue of Nature Immunology (Vol. 2, No. 5, 01 May 01), Pippa Marrack and colleagues from the University of Colorado Health Sciences Center, Denver, CO report on how adjuvants promote T cell survival.

Marrack and colleagues used "gene chips", a new technology that facilitates the identification of many genes at once, to compare the genes expressed by T cells in the presence or absence of adjuvant. Of the many differences in gene expression by T cells that are under the influence of adjuvants and those that are not, one gene in particular, called Bcl3, caught the investigators' eyes. Bcl3, which belongs to a family of genes that promote T cell survival, was specifically "switched on" by adjuvants during an immune response.

The Denver group then tested this gene and found that it does, indeed, increase the life expectancy of T cells that had been exposed to antigen, perhaps by regulating a series of genes that together make for a "hardier" T cell. In a N&V, Andreas Strasser from Melbourne, Australia outlines how these authors show "that Bcl-3 is a critical regulator" of the cell death process in T cells. Thus, it is likely that one way in which adjuvants improve the efficacy of vaccines is by switching on Bcl-3, whose presence promotes T cell survival.

CONTACT:

Philippa Marrack
National Jewish Medical and Research Center
HHMI
1400 Jackson Street, K 521
Denver, CO 80206-2761
U N I T E D S T A T E S
Tel: (+1) 303-398-1322
Fax: (+1) 303-398-1396
marrackp@njc.org

Andreas Strasser
The University of Melbourne
Royal Melbourne Hospital
The Walter and Eliza Hall Institute of Medical Research
Royal Parade, Parkville, Gate 12
Victoria 3050
A U S T R A L I A
Tel: (+61) 3 9345 2555
Fax: (+61) 3 9347 0852
strasser@wehi.edu.au

(C) Nature Immunology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.